Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $1.6 million.

  • Mangoceuticals' Cash from Financing Activities rose 11620.95% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 5002.85%. This contributed to the annual value of $4.1 million for FY2024, which is 4150.14% down from last year.
  • As of Q3 2025, Mangoceuticals' Cash from Financing Activities stood at $1.6 million, which was up 11620.95% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Mangoceuticals' Cash from Financing Activities peaked at $5.0 million during Q1 2023, and registered a low of $267500.0 during Q1 2024.
  • Over the past 3 years, Mangoceuticals' median Cash from Financing Activities value was $1.2 million (recorded in 2023), while the average stood at $1.6 million.
  • Per our database at Business Quant, Mangoceuticals' Cash from Financing Activities tumbled by 9465.0% in 2024 and then surged by 75420.56% in 2025.
  • Quarter analysis of 3 years shows Mangoceuticals' Cash from Financing Activities stood at $1.2 million in 2023, then decreased by 6.46% to $1.1 million in 2024, then soared by 44.46% to $1.6 million in 2025.
  • Its Cash from Financing Activities was $1.6 million in Q3 2025, compared to $1.3 million in Q2 2025 and $2.3 million in Q1 2025.